Since its recognition in December 2019 as a cause of potentially severe pneumonia, SARS-CoV-2 infection has rapidly spread globally, causing a pandemic. Although it is an infectious disease, several distinct manifestations have been described in the setting of the new coronavirus disease (COVID)-19 resulting from the hyperimmune response caused by the virus [1]. The heart is frequently involved in COVID-19 and is associated with severe outcomes. Numerous distinct cardiac complications have been reported in COVID-19 patients, including arrhythmia, myocarditis, and coronary thrombosis [2]. Pericarditis is rarely reported in COVID-19 patients, and no reports are available on its treatment and outcome [3]. Herein, we describe the case of a patient affected by COVID-19 complicated by pericarditis successfully treated with the IL-1R antagonist anakinra.
Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report / Karadeniz H.; Yamak B.A.; Ozger H.S.; Sezenoz B.; Tufan A.; Emmi G.. - In: CARDIOVASCULAR DRUGS AND THERAPY. - ISSN 0920-3206. - ELETTRONICO. - (2020), pp. 1-11. [10.1007/s10557-020-07044-3]
Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report
Emmi G.
2020
Abstract
Since its recognition in December 2019 as a cause of potentially severe pneumonia, SARS-CoV-2 infection has rapidly spread globally, causing a pandemic. Although it is an infectious disease, several distinct manifestations have been described in the setting of the new coronavirus disease (COVID)-19 resulting from the hyperimmune response caused by the virus [1]. The heart is frequently involved in COVID-19 and is associated with severe outcomes. Numerous distinct cardiac complications have been reported in COVID-19 patients, including arrhythmia, myocarditis, and coronary thrombosis [2]. Pericarditis is rarely reported in COVID-19 patients, and no reports are available on its treatment and outcome [3]. Herein, we describe the case of a patient affected by COVID-19 complicated by pericarditis successfully treated with the IL-1R antagonist anakinra.File | Dimensione | Formato | |
---|---|---|---|
s10557-020-07044-3.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
429.02 kB
Formato
Adobe PDF
|
429.02 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.